Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dale L. Bixby
Analysis of Transplantation Rate and Overall Treatment Efficacy by Age for Patients Aged 60 to 75 With Untreated Secondary Acute Myeloid Leukemia (AML) Given CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Correction To: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Drugs
Pharmacology
Healthcare Resource Utilization in a Phase 3 Study of CPX-351 in Patients With Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukemia
Journal of Medical Economics
Health Policy
Addition of Cladribine to Daunorubicin and Cytarabine Increases Complete Remission Rate After a Single Course of Induction Treatment in Acute Myeloid Leukemia. Multicenter, Phase III Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Phase I Study of Tipifarnib Combined With Conventional Induction and Consolidation Therapy for Previously Untreated Patients With Acute Myeloid Leukemia Aged 60 Years and Over
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Phase II Trial of Clofarabine and Daunorubicin as Induction Therapy for Acute Myeloid Leukemia Patients Greater Than or Equal to 60 Years of Age
Leukemia Research
Cancer Research
Oncology
Hematology
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia
Haematologica
Hematology
Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
Future Oncology
Medicine
Cancer Research
Oncology
Association Between Baseline Body Mass Index and Overall Survival Among Patients Over Age 60 With Acute Myeloid Leukemia
American Journal of Hematology
Hematology
